Oric Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

ORIC Pharmaceuticals

08/11/2021 23:16

* Oric Pharmaceuticals Inc  ORIC.OQ  reported a quarterly
adjusted loss of 47 cents​​ per share for the quarter ended in
September. The mean expectation of seven analysts for the
quarter was for a loss of 58 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Oric Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 47 cents​.
* The mean earnings estimate of analysts had fallen by
about 6.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Oric Pharmaceuticals Inc shares had fallen by 22.2% this
quarter and lost 52.0% so far this year.
* The company reported a quarterly loss of $18.43 million.
* Wall Street's median 12-month price target for Oric
Pharmaceuticals Inc is $30.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 8 at 11:16 p.m.
 ​All figures in US dollars unless otherwise stated